抑制骨形态发生蛋白信号通路可预防iPSC衍生神经元和PS19小鼠的tau病理
研究探讨衰老过程中骨形态发生蛋白(BMP)信号增强是否促进tau蛋白病发生发展。利用阿尔茨海默病(AD)患者诱导多能干细胞(iPSC)衍生神经元及PS19小鼠,发现BMP信号通过非经典p38通路增加tau磷酸化及p-tau释放,且与载脂蛋白E4(ApoE4)存在交互作用;抑制BMP信号可减少神经元tau改变,并限制PS19小鼠tau病理和预防认知下降。
要点
- BMP信号经非经典p38通路增加人iPSC衍生AD神经元tau磷酸化及p-tau释放。
- BMP信号与ApoE4交互作用较ApoE3神经元显著增加tau磷酸化及释放。
- 抑制BMP信号可限制PS19小鼠tau病理并预防认知下降。
核心结论
- 研究提示衰老相关的BMP信号增加可能参与tau病理的发生和进展。
- 作者认为减少衰老脑中BMP信号的治疗干预可能潜在减缓或预防涉及tau过度磷酸化的疾病发展。
研究设计与样本
- 使用AD患者iPSC衍生神经元研究BMP信号对tau磷酸化、释放的影响及机制。
- 使用野生型小鼠在体内检查BMP信号效应。
- 使用P301S(PS19)小鼠在tau蛋白病模型中检查BMP信号效应。
主要发现
- BMP信号经非经典p38信号介导,增加人iPSC衍生AD神经元tau磷酸化及p-tau释放。
- BMP信号与ApoE4交互作用,较ApoE3神经元显著增加tau磷酸化及释放。
- 抑制BMP信号减少培养人神经元中tau改变,并限制PS19小鼠tau病理、预防认知下降。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Many neurodegenerative disorders share a common pathologic feature involving the deposition of abnormal tau protein in the brain (tauopathies). This suggests that there may be some shared pathophysiologic mechanism(s). The largest risk factor for the majority of these disorders is aging, suggesting involvement of the aging process in the shared pathophysiology. We test the hypothesis that an increase in bone morphogenetic protein (BMP) signaling that occurs during aging contributes to the onset and progression of tauopathies. METHODS: Human induced pluripotent stem cell (iPSC)-derived neurons from patients with Alzheimer's disease (AD) were used to investigate the effects of BMP signaling on tau phosphorylation and release and the mechanisms underlying these effects. Wildtype mice were used to examine effects of BMP signaling in vivo. P301S (PS19) mice were examined for the effects of BMP signaling in a model of tauopathy. RESULTS: Here, we show that BMP signaling, mediated by non-canonical p38 signaling, increases tau phosphorylation and release of p-tau in human iPSC-derived AD neurons. Further, there is an interaction between BMP signaling and apolipoprotein E4 (ApoE4) that significantly increases tau phosphorylation and release compared with ApoE3 neurons. Inhibiting BMP signaling reduces the changes in tau in the cultured human neurons, and it limits tau pathology and prevents cognitive decline in PS19 mice. INTERPRETATION: Our study suggests that the age-related increase in BMP signaling may participate in the onset and progression of tau pathology. Thus, therapeutic interventions that reduce BMP signaling in the aging brain could potentially slow or prevent development of diseases involving tau hyperphosphorylation. ANN NEUROL 2025;97:657-672.
引用
- Affaneh A, Linden AK, Tunc-Ozcan E, et al. Inhibition of Bone Morphogenetic Protein Signaling Prevents Tau Pathology in iPSC Derived Neurons and PS19 Mice. Ann Neurol. 2024. PMID: 39644182. doi:10.1002/ana.27149
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。